← Open Payments lookup

KIMBERLY SCHOONOVER: Open Payments

NPI 1922710466 · CLARINDA, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$435 in 20 payments from 9 companies in 2025. Trend: 2023 $254 · 2024 $510 · 2025 $435

Food & beverage: $435
CompanyPaymentsAmount
Janssen Pharmaceuticals, Inc3$99
Alkermes, Inc.4$76
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$70
Collegium Pharmaceutical, Inc.3$60
ABBVIE INC.2$39
Takeda Pharmaceuticals U.S.A., Inc.2$35
Teva Pharmaceuticals USA, Inc.1$23
E.R. Squibb & Sons, L.L.C.1$17
Supernus Pharmaceuticals, Inc.1$16

Products named: INVEGA SUSTENNA, ARISTADA, CAPLYTA, Jornay PM, VRAYLAR, TRINTELLIX, UZEDY, COBENFY.

Industry payments across IA — which companies pay providers there.